Yurie Soejima

Dr. Yurie Soejima

Tokyo Medical and Dental University
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YSYurie Soejima
Yurie Soejima
MTMiho Takeuchi
Miho Takeuchi
TATakumi Akashi
Takumi Akashi
MSMotoji Sawabe
Motoji Sawabe
TFToshio Fukusato
Toshio Fukusato
Intrahepatic cholangiocarcinoma (ICC) is a heterogeneous group of cancers of the intrahepatic biliary tract. However, few studies have evaluated integrin expression according to an ICC subgroup. We immunohistochemically investigated α6β4 (β4) and αvβ6 (β6) integrin expressions in 48 ICCs, and evaluated their relationship with clinical and pathological parameters and ligand expression, as well as transforming growth factor (TGF)-β1. β4 and β6 expressions were detected in 46 (96%) and 35 (73%) ICC cases, respectively. We classified ICC into negative, low (β4, 29 cases; β6, 36 cases), or high (β4, 19 cases; β6, 12 cases) integrin expression groups. β4 and β6 integrin levels were higher in the non-peripheral central localization type ICC than in the peripheral localization type; they were also higher in the periductal-infiltrating or intraductal-growth types than in the mass-forming type ICC; lastly, they were higher in the well-differentiated type than in the poorly-differentiated type ICC. High expression was related to bile duct invasion. In addition, β4 and β6 expressions were associated with mucin production and the expression of cytoplasmic epithelial membrane antigen, laminin-5, and tenascin-C. TGF-β1 was correlated with β6 expression and poor overall survival. These results suggest that integrin expression is associated with subclassification and clinicopathological features of ICC through the coincident expression of their ligands and TGF-β1.

Verified
Journal Article
Open access
PDF file
YSYurie Soejima
Yurie Soejima
MTMiho Takeuchi
Miho Takeuchi
NMNao Miyamoto
Nao Miyamoto
MSMotoji Sawabe
Motoji Sawabe
TFToshio Fukusato
Toshio Fukusato
Intrahepatic cholangiocarcinoma (iCCA) is a heterogeneous bile duct cancer with a poor prognosis. Integrin αvβ6 (β6) has been shown to be upregulated in iCCA and is associated with its subclassification and clinicopathological features. In the present study, two ITGB6-knockout HuCCT1 CCA cell lines (ITGB6-ko cells) were established using the clustered regulatory interspaced short palindromic repeats (CRISPR), an associated nuclease 9 (Cas9) system, and single-cell cloning. RNA sequencing analysis, real-time polymerase chain reaction (PCR), and immunofluorescent methods were applied to explore possible downstream factors. ITGB6-ko cells showed significantly decreased expression of integrin β6 on flow cytometric analysis. Both cell lines exhibited significant inhibition of cell migration and invasion, decreased wound-healing capability, decreased colony formation ability, and cell cycle dysregulation. RNA sequencing and real-time PCR analysis revealed a remarkable decrease in podocalyxin-like protein 2 (PODXL2) expression in ITGB6-ko cells. Colocalization of PODXL2 and integrin β6 was also observed. S100 calcium-binding protein P and mucin 1, which are associated with CCA subclassification, were downregulated in ITGB6-ko cells. These results describe the successful generation of ITGB6-ko CCA cell clones with decreased migration and invasion and downregulation of PODXL2, suggesting the utility of integrin β6 as a possible therapeutic target or diagnostic marker candidate.

1 January 2012 in Kanzo
Verified
Journal Article
Open access
YSYurie Soejima
Yurie Soejima
FKFukuo Kondo
Fukuo Kondo
MIMasafumi Inoue
Masafumi Inoue
YTYoshihisa Takahashi
Yoshihisa Takahashi
KSKeiji Sano
Keiji Sano
TFToshio Fukusato
Toshio Fukusato

12 December 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
MKMayumi Kinoshita
Mayumi Kinoshita
MSMotoji Sawabe
Motoji Sawabe
YSYurie Soejima
Yurie Soejima
MMMakiko Mieno
Makiko Mieno
TATomio Arai
Tomio Arai
NHNaoko Honma
Naoko Honma
The predominant histological subtype of breast mucinous carcinoma in older women is type B (hypercellular type), and, in younger women, it is type A (hypocellular type). The characteristics of mucinous carcinomas of the same histological subtype may differ between older and younger women. This study aims to systematically clarify the pathological/immunohistochemical features of mucinous carcinomas. A total of 21 surgical cases of mucinous carcinoma (type A/B: 9/12 cases) in the older group (≥65 years) and 16 cases (type A/B: 14/2 cases) in the younger group (≤55 years) (n = 37) were included. Gross cystic disease fluid protein-15 (GCDFP-15) and eight other markers were used for immunostaining. The GCDFP-15-positive rate in the older group was high regardless of the histological subtype (type A, 77.8%; type B, 91.7%). The GCDFP-15 positivity in the older group was significantly higher than that in the younger group (p < 0.001 for Allred score). Among type A, GCDFP-15 positivity was significantly higher in the older group than in the younger group (p = 0.042 for the Allred score and p = 0.007 for the positivity rate). The present results suggest that GCDFP-15 expression characterizes mucinous carcinomas in older women.

1 September 2020 in Kanzo
Verified
Journal Article
Open access
PDF file
TTTakuo Tokairin
Takuo Tokairin
YKYohei Koshima
Yohei Koshima
HYHiroyuki Yoshidome
Hiroyuki Yoshidome
YSYurie Soejima
Yurie Soejima
AAAkiko Adachi
Akiko Adachi
FKFukuo Kondo
Fukuo Kondo
経口避妊薬の服用歴のない37才女性.健診で肝腫瘤を指摘され当施設紹介.腹部超音波検査で肝に径8 cmの結節内結節構造を呈する高エコー腫瘤を認めた.MRI-T1Wで低信号,T2Wで等信号.血管造影下CTの動脈早期相で多血性,後期相で低吸収域となり,周囲にコロナ様の濃染を認めた.肝針生検標本では異型に乏しい肝細胞から成り,免疫組織化学的にβ-catenin核内集積を認め,β-catenin活性化型肝細胞腺腫(b-HCA)と診断された.肝右葉切除術施行.切除標本には結節内結節構造を呈する径9.8 cm大の腫瘤を認め,遺伝子解析の結果,内側の結節のみにTERT promoter領域の遺伝子変異を認めた.本症例は経口避妊薬非服用女性に発生したb-HCAで,結節内結節構造の内側結節のみにTERT promoter領域の遺伝子変異が認められ,b-HCAの悪性転化を考える上で興味深い症例と思われたので報告した.

1 January 2020 in Proceedings for Annual Meeting of The Japanese Pharmacological Society
Verified
Journal Article
Open access
PDF file
JAJianbo An
Jianbo An
TNTaeko Naruse
Taeko Naruse
KHKunihiko Hinohara
Kunihiko Hinohara
YSYurie Soejima
Yurie Soejima
MSMotoji Sawabe
Motoji Sawabe
AKAkinori Kimura
Akinori Kimura
Atherosclerosis often results in high incidence of vascular occlusion and has been recognized as the major cause of coronary artery disease. We had previously reported that promoter polymorphism of myocardin-related transcription factor A (MRTF-A) is associated with coronary atherosclerosis. However, the contribution of MRTF-A to the development of atherosclerosis remains unclear. Macrophages are known to be important mediators of atherosclerosis. In this study, we found that MRTF-A was highly expressed in lesional macrophages in human carotid atherosclerotic plaque. To investigate the role of macrophagic MRTF-A in the pathogenesis of atherosclerosis, we generated ApoE null MRTF-A transgenic mice (ApoE−/−/MRTF-Atg/+), in which human MRTF-A was specifically overexpressed in monocytes/macrophages. We found that ApoE−/−/MRTF-Atg/+ aggravated atherosclerosis and accumulated prominent lesional macrophages in the aortic sinus. We also found that MRTF-A promoted proliferation of macrophages and mitigated apoptosis both in vitro and in vivo due to downregulation of the expression of cyclin-dependent kinase inhibitors. Taken together, our data indicated that MRTF-A contributes to the development of atherosclerosis by modulating functional properties of pro-atherogenic macrophages.